Congenital diaphragmatic hernia: prenatal prognosis and postnatal care
Congenital diaphragmatic hernia remains one of the more demanding anomalies encountered in perinatal medicine. The condition arises when the diaphragm fails to close during the eighth to tenth week of embryogenesis, allowing abdominal viscera to occupy the thorax and arrest normal lung development. Although survival has climbed meaningfully over recent decades, affected neonates still face substantial risks from pulmonary hypoplasia, persistent pulmonary hypertension, and a complex surgical recovery. Learn more about 筋力トレーニングによる筋肥大の分子基盤.
Prognosis is shaped far more by what is seen on imaging than by the size of the defect itself. Families, obstetricians, neonatologists, and paediatric surgeons weigh ultrasound findings, fetal MRI measurements, and associated anomalies to plan delivery, prepare extracorporeal support, and counsel parents on likely outcomes. A realistic prenatal picture empowers expectant mothers and their partners to make informed choices, especially when geographic relocation becomes necessary to reach a quaternary paediatric centre.
For clinicians working across Australia, the country's particular mix of state-funded tertiary networks, retrieval services, and rural distance shapes every decision. The Australian and New Zealand Neonatal Network (ANZNN) maintains one of the world's most complete neonatal datasets, and several Australian hospitals anchor international research into fetal therapy. This article walks through the embryology, prenatal prognostic markers, evolving fetal interventions, postnatal stabilisation, surgical technique, and the long arc of multidisciplinary follow-up.
Understanding the lesion and its origins
The diaphragm normally forms through fusion of the septum transversum, pleuroperitoneal membranes, and dorsal mesentery. Failure of closure produces a defect, most often posterolateral (Bochdalek), through which the stomach, spleen, intestine, and sometimes the liver can herniate into the chest. Left-sided lesions account for roughly 85 percent of cases, while right-sided and bilateral defects generally carry a more guarded outlook because of limited residual lung parenchyma.
Epidemiologically, the lesion affects approximately one in every 2,500 to 4,000 live births worldwide, with similar incidence captured by Australian perinatal registries. Isolated defects behave differently from syndromic hernias, where chromosomal anomalies such as trisomy 18, trisomy 13, or 45X compound morbidity and mortality. A detailed morphology scan that flags accompanying cardiac, genitourinary, or central nervous system anomalies often pivots parental counselling and triggers escalation to a multidisciplinary team at centres such as the Royal Children's Hospital in Melbourne or the Children's Hospital at Westmead in Sydney.
Targeted genetic evaluation is now a routine component of the workup in many tertiary Australian units. Karyotype and chromosomal microarray are typically offered first, with whole exome sequencing considered when results remain unrevealing but suspicion persists. Identifying a syndrome permits access to tailored bereavement support when prognosis is poor, or alternatively to staged surgical reconstruction and lifelong surveillance for those with isolated disease.
Antenatal detection and prognostic indicators
Most cases in Australia are picked up during the 18-to-20-week morphology scan offered through public hospitals or Medicare-rebated private obstetric care. Suspicious features include an absent or displaced stomach bubble, mediastinal shift, polyhydramnios, and an abnormally small thoracic circumference relative to the abdomen.
Validated prognostic measurements
- Lung-to-head ratio (LHR), an ultrasound measurement historically linked to poor outcomes when under 1.0.
- Observed-to-expected LHR (o/e LHR), now the preferred metric, expressed as a percentage; values under 25 percent suggest severe hypoplasia, while those above 45 percent predict reasonable survival.
- Liver herniation, where intrathoracic liver position markedly worsens prognosis and influences candidacy for fetal intervention.
- Fetal MRI volumetry, increasingly available in centres such as Brisbane's Mater Mother's Hospital, providing complementary assessment of residual lung parenchyma.
These indicators guide both family conversations and clinical planning. Mild disease may be delivered locally with postnatal transfer arranged; severe disease typically warrants delivery at a quaternary centre with paediatric surgical and extracorporeal membrane oxygenation (ECMO) capability.
Fetal therapy and perinatal planning
Fetoscopic endoluminal tracheal occlusion (FETO) has emerged as a viable option for severe left-sided lesions between 27 and 31 weeks of gestation. By inflating a detachable balloon in the fetal trachea, lung growth is stimulated through retained pulmonary fluid. Australian patients have accessed FETO through established referral pathways to international centres, while local trials continue to refine selection criteria.
Equally central is meticulous perinatal planning. A typical arrangement in a state like Queensland might involve identifying a family in Cairns or Townsville, coordinating antenatal corticosteroids, scheduling birth at around 38 weeks, and arranging aeromedical retrieval to a Brisbane NICU. The Royal Flying Doctor Service and LifeFlight support these complex transfers, where altitude exposure, oxygen titration, and temperature control matter for the ventilated neonate.
Counselling also touches maternal preventive health. Vaccination against influenza and pertussis lowers the chance of neonatal respiratory co-infection, which can be devastating in an infant with limited pulmonary reserve; readers may find the corresponding piece on maternal-immunization-during-pregnancy-influenza-and-pertussis on the FAOPS 2020 platform a useful companion for parent education.
| Indicator | Severe profile | Moderate profile | Mild profile |
|---|---|---|---|
| o/e LHR (ultrasound or MRI) | < 25% | 25–45% | > 45% |
| Liver herniation | Intrathoracic, major component | Intrathoracic, minor | Intra-abdominal only |
| Fetal MRI lung volume | < 20% of expected | 20–35% of expected | > 35% of expected |
| Associated anomalies | Major cardiac or chromosomal | Minor cardiac, no chromosomal | Isolated defect |
| Estimated survival | 30–50% | 60–75% | > 85% |
Postnatal stabilisation and surgical repair
Immediate management prioritises gentle ventilation, permissive hypercapnia, and avoidance of barotrauma, a philosophy championed by the international CDH Study Group and adopted across Australian NICUs from Perth to Hobart. Nasogastric decompression, pre-ductal pulse oximetry, and early echocardiography to assess pulmonary hypertension guide the first 24 to 72 hours of life.
For infants who fail conventional support, venoarterial or venovenous ECMO is offered at designated centres including the Royal Children's Hospital Melbourne, Westmead, and Perth's specialist paediatric unit, with strict criteria balancing bleeding risk against refractory hypoxaemia. Prostaglandin, inhaled nitric oxide, and milrinone remain complementary options for managing elevated pulmonary vascular resistance.
Surgical repair is typically delayed until cardiopulmonary stability is achieved, often between days five and fourteen. Both open subcostal and minimally invasive thoracoscopic approaches are practised in Australia, with the latter gaining favour for selected left-sided lesions without liver herniation. Success depends on an experienced paediatric anaesthetic team familiar with the patient's pulmonary vascular profile, and on a broader framework of neonatal neuroprotection; related advances are summarised in work on perinatal asphyxia biomarkers and neuroimaging hosted elsewhere on the FAOPS 2020 portal.
Long-term follow-up and family-centred care
Survivors of the lesion often face a complex trajectory well beyond hospital discharge. Chronic lung disease, gastro-oesophageal reflux, scoliosis, failure to thrive, sensorineural hearing loss, and neurodevelopmental delay are all recognised sequelae. Structured follow-up programmes, such as those run out of Perth Children's Hospital or the Royal Women's Hospital in Melbourne, coordinate pulmonology, cardiology, surgical, and developmental review through to school age.
Support pathways for Australian families
- NDIS access for eligible children with permanent disability, funding therapy, equipment, and family respite.
- Local branches of CDH parent support networks, providing peer mentoring and lived-experience guidance.
- State-funded early childhood intervention services, including physiotherapy, dietetics, and speech pathology.
- Telehealth outreach to rural and remote families, a service dramatically expanded since the early 2020s.
The transition into adolescence and adulthood requires ongoing vigilance, particularly for those needing fundoplication revisions, spinal surgery, or assessment of exercise tolerance. Recovery of muscle strength and endurance shapes longer-term quality of life, and foundational work on muscle hypertrophy mechanisms offers a useful parallel reference for clinicians advising families on age-appropriate activity.
Clinicians and families are invited to explore the wider scientific programme, abstracts, and educational resources hosted on this platform. The recorded symposia, poster collections, and accompanying commentary remain available for review, supporting continued learning across the perinatal community throughout 2020 and beyond.
